SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-208257
Filing Date
2011-08-03
Accepted
2011-08-03 16:31:29
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 596788
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex311.htm EX-31.1 10279
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) dex312.htm EX-31.2 10310
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5305
  Complete submission text file 0001193125-11-208257.txt   2147896

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jazz-20110630.xml EX-101.INS 267571
6 XBRL TAXONOMY EXTENSION SCHEMA jazz-20110630.xsd EX-101.SCH 12964
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jazz-20110630_cal.xml EX-101.CAL 37678
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20110630_lab.xml EX-101.LAB 110878
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20110630_pre.xml EX-101.PRE 75192
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 111007313
SIC: 2834 Pharmaceutical Preparations